Arecor Therapeutics plc (FRA:6UI)

Arecor Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	37	34	64	83	133	-
Market Cap Growth	18.12%	-47.90%	-22.25%	-37.50%	-	-
Enterprise Value	35	31	55	68	107	-
Last Close Price	0.88	0.85	2.06	2.62	2.90	-
PS Ratio	6.34	5.49	12.22	30.58	96.15	-
PB Ratio	11.23	5.19	5.87	4.21	6.00	-
P/TBV Ratio	11.33	5.22	8.97	5.23	6.01	-
EV/Sales Ratio	6.08	5.04	10.46	24.94	77.27	-
Debt / Equity Ratio	0.06	0.04	0.04	0.02	0.01	2.58
Asset Turnover	0.65	0.42	0.25	0.11	0.09	0.40
Inventory Turnover	12.39	5.62	3.49	-	-	-
Quick Ratio	2.00	2.08	1.96	4.19	8.77	2.67
Current Ratio	2.05	2.53	2.17	4.69	9.05	2.71
Return on Equity (ROE)	-204.28%	-137.62%	-63.41%	-51.44%	-63.85%	-138.22%
Return on Assets (ROA)	-44.39%	-38.43%	-30.88%	-30.28%	-29.64%	-49.89%
Return on Capital (ROIC)	-82.64%	-59.96%	-41.54%	-35.39%	-34.67%	-69.84%
Return on Capital Employed (ROCE)	-189.60%	-135.50%	-89.70%	-57.30%	-32.00%	-119.20%
Earnings Yield	-25.26%	-36.88%	-15.30%	-12.60%	-5.54%	-
FCF Yield	-19.40%	-33.07%	-10.72%	-15.08%	-4.96%	-
Buyback Yield / Dilution	-20.82%	-9.20%	-5.83%	-25.63%	-41.77%	-3.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.